Company attributes
Location
B2X
Legal Name
Jupiter Orphan Therapeutics, Inc.
Legal classification
Date Incorporated
2015
Email Address
info@jupiterneurosciences.com
Full Address
601 Heritage Dr Ste 138-139 Jupiter, FL, 33458-2777 United States
CIK Number
Investors
Total Funding Amount (USD)
6,351,000
Latest Funding Round Date
December 2017
Also Known As
JoT
Latest Funding Type
Country
Other attributes
Company Operating Status
Active
JOT focuses on the development of clinical stage drugs for the treatment of illnesses affecting the central nervous system (CNS). JOT's proprietary JOTROL™ platform provides a unique resveratrol-based treatment which can be used to treat Alzheimer's and other rare diseases. The company was founded in 2015 by Christer Rosén and Jacob Uittenbogaard and is headquartered in Jupiter, Florida.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
